European Union kwadoro ọgwụ COVID-19 mbụ

Ụlọ ọrụ na-ahụ maka ọgwụ na Europe (EMA) ekwupụtala na ọ nyela ikike ịzụ ahịa ahịa (CMA) maka ọgwụgwọ ọnụ ọnụ nke Pfizer. Paxlovid.

N'ime mgbasa nke nje na-aga n'ihu omicron nje n'ime Europe, EMA kwuru na akwadoro ọgwụ ọgwụgwọ coronavirus nke mbụ “maka ọgwụgwọ COVID-19 na ndị okenye na-adịghị achọ oxygen mgbakwunye yana ndị nwere nnukwu ihe ize ndụ nke ọrịa ahụ na-esiwanye ike.”

A na-eji usoro CMA, EMA kwuru, iji mee ka usoro ikike nke ọgwụ dị ngwa ngwa "n'oge ihe mberede ahụike ọha."

Site na nkwado nke ndị na-ahụ maka ndị Europe. Paxlovid abụrụla ọgwụ mgbochi mbụ a na-enye site n'ọnụ nke a tụrụ aro na EU maka ọgwụgwọ COVID-19.

Nkwenye nke Paxlovid na-esote ikike na Disemba nke ọgwụgwọ mgbochi mmadụ Xevudy, nke GlaxoSmithKline na Vir Biotechnology mepụtara, yana Kineret nke ụlọ ọrụ Sweden bụ Sobi, nke bụbu ọgwụ ogbu na nkwonkwo mana nwee ike “belata” mbufụt metụtara COVID.

Onye asọmpi Paxlovid, Merck's Lagevrio (molnupiravir), ka EMA na-enyocha ya, n'ihi na arụmọrụ ya egosila na ọ dị ala karịa ka a tụrụ anya ya.

Ma Paxlovid na molnupiravir nwetara nkwado site na nchịkwa nri na ọgwụ US na Disemba afọ gara aga.